40

: Valsartan Dexcel 40. ?  »
|
-

PER OS

Film Coated Tablets

Valsartan is indicated for the treatment of heart failure (NYHA class II-IV) in patients who are intolerant of angiotensin converting enzyme inhibitors. In a controlled clinical trial Valsartan significantly reduced hospitalisations for heart failure. There is no evidence that Valsartan provides added benefits when it is used with an adequate dose of an ACE inhibitor. Valsartan is indicated to improve survival following myocardial infarction in clinically stable patients with signs symptoms or radiological evidence of left ventricular failure and /or with left ventricular systolic dysfunction.

147 19 33424 00

Dexcel Ltd

01/2012 - 12/2016

.
, .
.
/
Valsartan 40 MG
Blister pvc/pvdc/aluminium 2 x TABLETS 36
Blister pvc/pvdc/aluminium 5 x TABLETS 36
Blister pvc/pvdc/aluminium 7 x TABLETS 36
Blister pvc/pvdc/aluminium 10 x TABLETS 36
Blister pvc/pvdc/aluminium 14 x TABLETS 36
Blister pvc/pvdc/aluminium 15 x TABLETS 36
Blister pvc/pvdc/aluminium 20 x TABLETS 36
Blister pvc/pvdc/aluminium 21 x TABLETS 36
Blister pvc/pvdc/aluminium 28 x TABLETS 36
Blister pvc/pvdc/aluminium 30 x TABLETS 36
Blister pvc/pvdc/aluminium 50 x TABLETS 36
Blister pvc/pvdc/aluminium 56 x TABLETS 36
Blister pvc/pvdc/aluminium 60 x TABLETS 36

*

*

 

.

?

!
!
 »
 
" !
 
278
,